Work

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

Year: 2010

Type: article

Study design: Clinical Trial

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-009-0678-5

Authors: Alejandra T. Perez, Banu Arun, Debu Tripathy, Mary A. Tagliaferri, Heather S. Shaw, Gretchen G. Kimmick, Isaac Cohen, Emma Shtivelman, Katherine A. Caygill, Deborah Grady, Mark Schactman, Charles L. Shapiro

Institutions: Memorial Healthcare System, The University of Texas MD Anderson Cancer Center, University of Southern California, Bionovo (United States), University of North Carolina at Chapel Hill, Duke Medical Center, University of California, San Francisco, Statistics Collaborative, The Ohio State University Wexner Medical Center

Language: English

Topic: Complementary and Alternative Medicine Studies

Subfield: Complementary and alternative medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2120131311

FWCI: 23.86

Cites: 12

Cited by: 92

Related to: 10